Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHA/688235 stock hub

SHA/688235 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/688235is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

236B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/688235

In the news

Latest news · SHA/688235

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E42.7

P25 17.1P50 24.2P75 37.8

Trailing P/E66.7

P25 23.5P50 41.3P75 83.2

ROE12.4

P25 -0.9P50 4.1P75 8.8

ROIC53.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/688235 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

194

Groups with data

Currency

USD

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	CN
Employees	12,000
Employees Change	400%
Employees Change Percent	3.77
Enterprise value	CNY 211.2B
Exchange	Shanghai Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100005XT6
Last refreshed	2026-05-10
Market cap	CNY 236B
Price	CNY 248
Price currency	CNY
Rev Per Employee	3,298,791.91x
Sector	Healthcare
Sic	2836
Symbol	sha/688235
Website	https://beonemedicines.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.5%
EV Earnings	59.69x
EV/EBIT	45.38x
EV/EBITDA	36.37x
EV/FCF	27.47x
EV/Sales	5.41x
FCF yield	3.26%
Forward P/E	42.67x
P/B ratio	7.19x
P/E ratio	66.69x
P/S ratio	5.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.95%
EBITDA Margin	14.38%
FCF margin	19.42%
Gross margin	88.31%
Gross Profit	CNY 35B
Gross Profit Growth	43.11%
Gross Profit Growth Q	41.37%
Gross Profit Growth3 Y	45.54%
Net Income	CNY 3.5B
Net Income Growth Q	17,802.13%
Net Income Growth Quarters	5%
Net Income Growth Years	3%
Pretax Margin	11.42%
Profit Margin	8.94%
Profit Per Employee	CNY 294,875
Profitable Years	1
ROA	5.96
Roa5y	-8.44
ROCE	10.17
ROE	12.42
Roe5y	-20.17
ROIC	53.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	3.78%
Cagr3y	16.99%
EPS Growth Q	16,970.8
EPS Growth Quarters	5
EPS Growth Years	3
OCF Growth	505.99%
OCF Growth Q	356.73%
Revenue Growth	37.44x
Revenue Growth Q	35.46x
Revenue Growth Quarters	15x
Revenue Growth Years	5x
Revenue Growth3 Y	54.47x
Revenue Growth5 Y	46.08x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.8
Assets	CNY 59B
Cash	CNY 33.1B
Current Assets	CNY 44.9B
Current Liabilities	CNY 12.3B
Debt	CNY 7.9B
Debt EBITDA	CNY 1.34
Debt Equity	CNY 0.24
Debt FCF	CNY 1.03
Equity	CNY 32.8B
Interest Coverage	8.15
Liabilities	CNY 26.2B
Long Term Assets	CNY 14.1B
Long Term Liabilities	CNY 13.8B
Net Cash	CNY 25.1B
Net Cash By Market Cap	CNY 10.65
Net Cash Growth	139.72%
Net Debt EBITDA	CNY -4.41
Net Debt Equity	CNY -0.77
Net Debt FCF	CNY -3.27
Tangible Book Value	CNY 32.4B
Tangible Book Value Per Share	CNY 292
WACC	6.97

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.64
Inventory Turnover	1.14
Net Working Capital	CNY 929.9M
Quick ratio	3.17
Working Capital	CNY 33B
Working Capital Turnover	CNY 11.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	3.77%
200-day SMA	268.1
3Y total return	60.12%
50-day SMA	240.6
50-day SMA vs 200-day SMA	50under200
All Time High	346
All Time High Change	-28.47%
All Time High Date	2025-09-02
All Time Low	82
All Time Low Change	201.83%
All Time Low Date	2022-04-27
ATR	9.45
Beta	0.5
Ch YTD	-7.86
High	257.4
High52	346
High52 Date	2025-09-02
High52ch	-28.47%
Low	247
Low52	213.3
Low52 Date	2026-03-23
Low52ch	16.02%
Ma50ch	2.87%
Price vs 200-day SMA	-7.69%
RSI	54.09
RSI Monthly	55.29
RSI Weekly	46.46
Sharpe ratio	0.12x
Sortino ratio	0.32
Total Return	-8.16%
Tr YTD	-7.86
Tr1m	4.38%
Tr1w	0.26%
Tr3m	-9.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 4.7B
Operating Income Growth Q	2,151
Operating margin	11.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	78,053,286%
Net Borrowing	1,030,321,200
Shares Qo Q	0.34%
Shares Yo Y	8.16%
Short Ratio	4.95

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 4B
Average Volume	3,398,818.3x
Bv Per Share	295.5
CAPEX	CNY -1.2B
Ch1m	4.38
Ch1w	0.26
Ch1y	3.77
Ch3m	-9.17
Ch3y	60.12
Ch6m	-11.29
Change	-2.71%
Change From Open	-2.71
Close	254.4
Days Gap	0
Depreciation Amortization	952,261,617.6
Dollar Volume	1,004,765,850
Earnings Date	2026-04-15
EBIT	CNY 4.7B
EBITDA	CNY 5.7B
EPS	CNY 30.38
F Score	7
FCF	CNY 7.7B
FCF EV Yield	3.64x
Financing CF	8,013,813,164
Fiscal Year End	December
Founded	2,010
Graham Number	53.62618
Graham Upside	-78.33
Income Tax	CNY 980.5M
Investing CF	-1,377,576,318
Is Primary Listing	0
Last Earnings Date	2026-04-15
Last Report Date	2026-03-31
Ma150	271.3
Ma150ch	-8.79%
Ma20	242.9
Ma20ch	1.89%
Net CF	16,021,515,232
Next Earnings Date	2026-08-31
Open	254.4
P FCF Ratio	30.69
P OCF Ratio	26.63
Position In Range	4.81
Ppne	12,149,051,132
Price Date	2026-05-08
Price EBITDA	CNY 41.45
Ptbv Ratio	7.28
Relative Volume	1.22x
Revenue	39,585,502,901x
SBC By Revenue	9.39x
Share Based Comp	3,715,863,892
Tax By Revenue	2.48x
Tax Rate	21.7%
Tr6m	-11.29%
Volume	4,059,660
Z Score	5.51

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SHA/688235 pay a dividend?

Capital-return profile for this ticker.

Performance

SHA/688235 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/688235?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SHA/688235 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.1

Neutral momentum band

Price vs 200-day MA

-7.7%

50/200-day relationship not available

Beta (5Y)

0.50

Less volatile than the market

Sharpe ratio

0.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/688235

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688235 stock rating?

sha/688235 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688235 analysis?

The full report lives at /stocks/sha/688235/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688235?

The latest report frames sha/688235 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688235 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.